Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Ethnic, racial, and geographic disparities in idiopathic thrombocytopenic purpura related mortality along the US-Mexico border from 1999 to 2020

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAllahdad KhanSASiti Rozaimah Sheikh Abdullah

Discussion

Loading...

Member takes

Overview

Analysis reveals idiopathic thrombocytopenic purpura mortality increased in non-Hispanic Whites and older age groups, indicating critical healthcare access gaps.

Key Points

  • ITP-related mortality significantly decreased from 1999 to 2020 along the US-Mexico border.
  • Non-Hispanic Whites faced higher mortality rates compared to other racial groups and age groups.
  • Analysis utilized CDC WONDER data to compute mortality rates across various demographics.
  • Findings highlight a need for improved healthcare access and management for high-risk populations.

Cite This Study

Khan et al. (2025) studied this question.

synapsesocial.com/papers/69362f604fa91c937236dd19https://doi.org/10.1182/blood-2025-7991
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trends and disparities in immune thrombocytopenic purpura-related mortality in the United States: a retrospective study over 24 years2025
  2. 2Thrombotic thrombocytopenic purpura-related mortality trends among the United States population: A retrospective study using the CDC wonder database2025
  3. 3The unseen bleed- temporal and demographic patterns of thrombocytopenia mortality in the United States: A 25-year analysis of the CDC wonder database2025
  4. 4Rapid decrease in age-adjusted mortality rates associated with ITP following eltrombopag aand romiplostin approvals, but not in TMA following eculizumab approval, 1999-20232025
  5. 5Disparities in autoimmune hemolytic Anemia–Related mortality in the u.S.–Mexico border region, 1999–2020: A CDC wonder study.2025